MedTrace Logo

Quality of Life Post-ACS in Participants from EMMACE

NCT04598048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13400

Last updated 2025-03-30

No results posted yet for this study

Summary

EMMACE-XL will recruit participants who are survivors of acute coronary syndrome (a type of heart attack) to assess their health-related quality of life five years or more after their heart attack. We will invite surviving participants from the EMMACE 3 and 4 studies to consent to participate in EMMACE-XL study, they will be asked to complete one questionnaire relating to their health, medication and lifestyle. The questionnaire will be linked to their data collected as part of the EMMACE 3 and 4 studies including long term follow up data from NHS Digital.

The data collected from all the studies will then be analysed to see if patient groups can be identified who are at risk of poorer quality of life and worse health outcomes. These groups can then be targeted with the aim of improving their health outcomes.

The study will use statistical methods to look at the relationship of factors such as; medication adherence, comorbidities and patient demographics on health-related quality of life and health outcomes.

Conditions

Interventions

BEHAVIORAL

Questionnaire

Patients will complete an EQ-5D questionnaire, medication and lifestyle questions

Sponsors & Collaborators

  • University of Leeds

    lead OTHER

Principal Investigators

  • Chris P Gale, Prof · University of Leeds

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-27
Primary Completion
2021-03-31
Completion
2024-11-08

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04598048 on ClinicalTrials.gov